Lipids-based nanostructured lipid carriers (NLCs) for improved oral bioavailability of sirolimus

Drug Delivery

Volumn 23, Issue 4, 2016, Pages 1469-1475

  Yu, Qin ^a   Hu, Xiongwei ^a   Ma, Yuhua ^a   Xie, Yunchang ^a   Lu, Yi ^a   Qi, Jianping ^a   Xiang, Li ^b   Li, Fengqian ^b   Wu, Wei ^a  

^a FUDAN UNIVERSITY   (China)

^b Central Laboratory   (China)

Author keywords

Drug delivery; nanoparticles; nanostructured lipid carriers; oral bioavailability; sirolimus

Indexed keywords

ASCOMYCIN; DRUG CARRIER; GLYCEROL; NANOSTRUCTURED LIPID CARRIER; OLEIC ACID; POLYSORBATE 80; RAPAMYCIN; UNCLASSIFIED DRUG; LIPID; NANOPARTICLE;

ANIMAL EXPERIMENT; ARTICLE; BEAGLE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG RELEASE; IN VITRO STUDY; LIPOLYSIS; MALE; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; ANIMAL; BIOAVAILABILITY; CHEMISTRY; DOG; ORAL DRUG ADMINISTRATION; SOLUBILITY;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; DOGS; DRUG CARRIERS; LIPIDS; NANOPARTICLES; SIROLIMUS; SOLUBILITY;

EID: 84961198338     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2016.1153744     Document Type: Article

References (30)

1. J.E.Araújo, M.A.Gonzalez-Mira, M.L.Egea,. (2010). Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications. Int J Pharm 393:168–76
2. S.G.Barnwell, T.Laudanski, M.J.Story,. (1992). Improved oral bioavailability of propranolol in healthy human volunteers using a liver bypass drug delivery system containing oleic acid. Int J Pharm 88:423–32
3. S.Das, W.K.Ng, R.H.Tan (2012). Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci 47:139–51
4. A.Haeri, S.Sadeghian, S.Rabbani,. (2013). Sirolimus-loaded stealth colloidal systems attenuate neointimal hyperplasia after balloon injury: a comparison of phospholipid micelles and liposomes. Int J Pharm 455:320–30
5. X.Hu, C.Lin, D.Chen,. (2012). Sirolimus solid self-microemulsifying pellets: formulation development, characterization and bioavailability evaluation. Int J Pharm 438:123–33
6. X.Hu, J.Zhang, Z.Yu,. (2015). Environment-responsive aza-BODIPY dyes quenching in water as potential probes to visualize the in vivo fate of lipid-based nanocarriers. Nanomedicine 11:1939–48
7. F.Ibrahim, P.Gershkovich, O.Sivak,. (2012). Assessment of novel oral lipid-based formulations of amphotericin B using an in vitro lipolysis model. Eur J Pharm Sci 46:323–8
8. M.S.Kim, J.S.Kim, W.Cho,. (2013). Supersaturatable formulations for the enhanced oral absorption of sirolimus. Int J Pharm 445:108–16
9. D.W.Kubiak, S.Koo, S.P.Hammond,. (2012). Safety of posaconazole and sirolimus coadministration in allogeneic hematopoietic stem cell transplants. Biol Blood Marrow Transplant 18:1462–5
10. Y.Liu, L.Wang, Y.Zhao,. (2014). Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin. Int J Pharm 476:169–77
11. R.H.Müller, M.Radtke, S.A.Wissing (2002). Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 242:121–8
12. A.MacDonald, J.Scarola, J.T.Burke,. (2000). Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus. Clin Ther 22:B101–21
13. P.McEwan, K.Baboolal, P.Conway,. (2005). Evaluation of the cost-effectiveness of Sirolimus versus cyclosporin for immunosuppression after renal transplantation in the United Kingdom. Clin Ther 27:1834–46
14. G.Moreno-Bautista, K.C.Tam (2011). Evaluation of dialysis membrane process for quantifying the in vitro drug-release from colloidal drug carriers. Colloid Surf A: Physicochem Eng Asp 389:299–303
15. H.Mu, R.Holm, A.Müllertz (2013). Lipid-based formulations for oral administration of poorly water-soluble drugs. Int J Pharm 453:215–24
16. H.Mu, C.E.Høy (2004). The digestion of dietary triacylglycerols. Prog Lipid Res 43:105–33
17. C.M.O’Driscoll (2002). Lipid-based formulations for intestinal lymphatic delivery. Eur J Pharm Sci 15:405–15
18. C.J.H.Porter, W.N.Charman (2001). In vitro assessment of oral lipid based formulations. Adv Drug Deliv Rev 50:S127–47
19. C.W.Pouton, C.J.H.Porter (2008). Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev S 60:625–37
20. M.A.Rouf, E.Bilensoy, İ.Vural,. (2007). Inclusion complexation of rapamycin with beta-cyclodextrin to improve solubility and stability of the drug. Eur J Pharm Sci 32:S46–7
21. M.Shangguan, Y.Lu, J.Qi,. (2014). Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin. J Biomater Appl 28:887–96
22. M.Shangguan, J.Qi, Y.Lu,. (2015). Comparison of the oral bioavailability of silymarin-loaded lipid nanoparticles with their artificial lipolysate counterparts: implications on the contribution of integral structure. Int J Pharm 489:195–202
23. P.Simamora, J.M.Alvarez, S.H.Yalkowsky (2001). Solubilization of rapamycin. Int J Pharm 213:25–9
24. T.Solymosi, R.Angi, O.Basa Dénes,. (2015). Sirolimus formulation with improved pharmacokinetic properties produced by a continuous flow method. Eur J Pharm Biopharm 94:135–40
25. M.Sun, X.Zhai, K.Xue,. (2011). Intestinal absorption and intestinal lymphatic transport of sirolimus from self-microemulsifying drug delivery systems assessed using the single-pass intestinal perfusion (SPIP) technique and a chylomicron flow blocking approach: linear correlation with oral bioavailabilities in rats. Eur J Pharm Sci 43:132–40
26. Z.Tian, Y.Yi, H.Yuan,. (2013). Solidification of nanostructured lipid carriers (NLCs) onto pellets by fluid-bed coating: preparation, in vitro characterization and bioavailability in dogs. Powder Technol 247:120–7
27. C.J.E.Watson, J.A.Bradley (2006). Sirolimus and everolimus: inhibitors of mammalian target of rapamycin in liver transplantation. Transplant Rev 20:104–14
28. S.A.Wissing, O.Kayser, R.H.Müller (2004). Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 56:1257–72
29. J.Zhang, P.X.Ma (2013). Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective. Adv Drug Deliv Rev 65:1215–33
30. C.Y.Zhuang, N.Li, M.Wang,. (2010). Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Int J Pharm 394:179–85